172 related articles for article (PubMed ID: 26740212)
1. Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival.
Liu CC; Teh R; Mozar CA; Baxter RC; Rasmussen HH
Breast Cancer Res Treat; 2016 Jan; 155(2):203-13. PubMed ID: 26740212
[TBL] [Abstract][Full Text] [Related]
2. Displacement of Native FXYD Protein From Na
Liu CC; Kim YJ; Teh R; Garcia A; Hamilton EJ; Cornelius F; Baxter RC; Rasmussen HH
Front Oncol; 2022; 12():859216. PubMed ID: 35371992
[TBL] [Abstract][Full Text] [Related]
3. A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.
Bibert S; Aebischer D; Desgranges F; Roy S; Schaer D; Kharoubi-Hess S; Horisberger JD; Geering K
Mol Biol Cell; 2009 Feb; 20(4):1132-40. PubMed ID: 19109419
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
5. FXYD3 (Mat-8), a new regulator of Na,K-ATPase.
Crambert G; Li C; Claeys D; Geering K
Mol Biol Cell; 2005 May; 16(5):2363-71. PubMed ID: 15743908
[TBL] [Abstract][Full Text] [Related]
6. [Synergic effect of Na(+)-K(+) ATPaseB1 and adriamycin on inhibition of cell proliferation and reversal of drug resistance in breast cancer MCF-7 cells].
Qi YY; Liu K; Zhang J; Li K; Ren JJ; Lin P
Ai Zheng; 2009 Aug; 28(8):861-7. PubMed ID: 19664334
[TBL] [Abstract][Full Text] [Related]
7. FXYD3 facilitates Na
Cano Portillo C; Villacreses R; Thurman AL; Pezzulo AA; Zabner J; Thornell IM
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1044-C1051. PubMed ID: 35993520
[TBL] [Abstract][Full Text] [Related]
8. FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.
Bibert S; Liu CC; Figtree GA; Garcia A; Hamilton EJ; Marassi FM; Sweadner KJ; Cornelius F; Geering K; Rasmussen HH
J Biol Chem; 2011 May; 286(21):18562-72. PubMed ID: 21454534
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity.
McDonald C; Muhlbauer J; Perlmutter G; Taparra K; Phelan SA
Int J Oncol; 2014 Jul; 45(1):219-26. PubMed ID: 24789097
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
11. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional properties of two human FXYD3 (Mat-8) isoforms.
Bibert S; Roy S; Schaer D; Felley-Bosco E; Geering K
J Biol Chem; 2006 Dec; 281(51):39142-51. PubMed ID: 17077088
[TBL] [Abstract][Full Text] [Related]
13. Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells.
Salyer SA; Olberding JR; Distler AA; Lederer ED; Clark BJ; Delamere NA; Khundmiri SJ
Biochim Biophys Acta; 2013 Oct; 1832(10):1734-43. PubMed ID: 23639630
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
15. FXYD1 negatively regulates Na(+)/K(+)-ATPase activity in lung alveolar epithelial cells.
Wujak ŁA; Blume A; Baloğlu E; Wygrecka M; Wygowski J; Herold S; Mayer K; Vadász I; Besuch P; Mairbäurl H; Seeger W; Morty RE
Respir Physiol Neurobiol; 2016 Jan; 220():54-61. PubMed ID: 26410457
[TBL] [Abstract][Full Text] [Related]
16. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
[TBL] [Abstract][Full Text] [Related]
17. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
Söderlund K; Pérez-Tenorio G; Stål O
Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
[TBL] [Abstract][Full Text] [Related]
18. Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.
Lee SJ; Litan A; Li Z; Graves B; Lindsey S; Barwe SP; Langhans SA
Mol Cancer; 2015 Aug; 14():159. PubMed ID: 26286140
[TBL] [Abstract][Full Text] [Related]
19. Effects of RNA interference-mediated silencing of toll-like receptor 4 gene on proliferation and apoptosis of human breast cancer MCF-7 and MDA-MB-231 cells: An in vitro study.
Gao XL; Yang JJ; Wang SJ; Chen Y; Wang B; Cheng EJ; Gong JN; Dong YT; Liu D; Wang XL; Huang YQ; An DD
J Cell Physiol; 2018 Jan; 234(1):433-442. PubMed ID: 29932226
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.
Okudela K; Yazawa T; Ishii J; Woo T; Mitsui H; Bunai T; Sakaeda M; Shimoyamada H; Sato H; Tajiri M; Ogawa N; Masuda M; Sugimura H; Kitamura H
Am J Pathol; 2009 Dec; 175(6):2646-56. PubMed ID: 19893046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
